Research Projects
Neuroimaging provides a multitude of non-invasive methods to better understand the pathology and pathogenesis of neurological and neuropsychiatric...
Supervisor: Dr Lucy Vivash
Impact of pregnancy on long-term outcomes in women with multiple sclerosis – assessment of mechanism
Data suggests that pregnancy in women with multiple sclerosis (MS) may exert long-term health benefits. Comparisons of women with and without...
Supervisor: Associate Professor Vilija Jokubaitis
Abusive head trauma (AHT) is a devastating condition that causes profound disability in millions of children worldwide. Significant knowledge gaps...
Supervisor: Professor Richelle Mychasiuk
Traumatic brain injury (TBI) is a complex and costly worldwide phenomenon that can lead to many negative health outcomes including disrupted...
Supervisor: Professor Richelle Mychasiuk
Chronic pain initially presents itself acutely without indication that it will persist; making it difficult to catch before it develops and equally...
Supervisor: Professor Richelle Mychasiuk
Antiepileptic drug is the mainstay of treatment modality for epilepsy. People with epilepsy often require lifelong antiepileptic drug treatment....
Supervisor: Professor Patrick Kwan
The current standard of care for epilepsy is to commence treatment with a single antiseizure medication (ASM) and if it fails, try successive drug...
Supervisor: Professor Patrick Kwan
Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is...
Supervisor: Professor Patrick Kwan
The ability of the adult nervous system to adapt/remodel across the lifespan (and
importantly after stroke) offers potential for brain recovery...
Supervisor: Dr Sharon Kramer
How do brain waves control cognitive processes? Using a combination of in vivo electrophysiology and sophisticated cognitive paradigms of working...
Supervisor: Assoc Professor Nigel Jones
Current therapies for epilepsy are symptomatic, only suppressing the symptoms (seizures), but do not impact the development or progression of disease...
Supervisor: Dr Pablo Casillas-Espinosa MD, PhD
People may develop epilepsy at any time throughout their life, and there are many different causes of epilepsy. This study will identify whether...
Supervisor: Dr Emma Foster
Epilepsy is a brain disorder affecting 1% of population. Patients can acquire post-traumatic epilepsy from a traumatic brain injury after a latent...
Supervisor: Dr Idrish Ali
Introduction: Epilepsy is a devastating neurological disorder that affects around 50 million people worldwide. Patients with acquired epilepsy, one...
Supervisor: Dr Idrish Ali
Mainstream anti-epileptic drugs (AEDs) that are used to treat epilepsy and some other conditions are associated with a range of cutaneous side...
Supervisor: Professor Patrick Kwan
Stroke survivors are at increased risk of acute symptomatic seizures in the days following a stroke, and are at increased risk for developing...
Supervisor: Dr Emma Foster
Description
Brain inflammation appears to play a critical role in the pathogenesis of epilepsy. A major cell type involved in inflammatory cascades...
Supervisor: Dr Idrish Ali
Frontotemporal dementia (FTD) is generally due to abnormalities either in a protein called tau (45%) or a protein called TDP-43 (45%). In both types...
Supervisor: Professor Terence O'Brien
Epilepsy is a serious neurological condition which is characterised by spontaneous seizures, or 'fits'. Current medications are effective...
Supervisor: Assoc Professor Nigel Jones
The glymphatic system is the brain's method for clearing waste products to allow for appropriate functioning. In certain diseases, this system...
Supervisor: Assoc Professor Nigel Jones